DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17

Clinical trials for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 explained in plain language.

Never miss a new study

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 trials appear

Sign up with your email to follow new studies for DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

Could a simple zinc pill help control a rare neurological disorder?

Disease control Completed

This small pilot study tested whether taking a daily zinc supplement for six months is safe and practical for people with GNAO1-related disorders. The main goal was to see if patients could stick to the daily regimen and to check for side effects. Researchers also looked for any …

Matched conditions: DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17

Phase: PHASE2 • Sponsor: Children's University Hospital Cologne, Germany • Aim: Disease control

Last updated Apr 04, 2026 07:36 UTC

DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17

Get alerted when new DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 17 trials appear

Could a simple zinc pill help control a rare neurological disorder?